A high-profile gene therapy biotech takes aim at Huntington's

A high-profile gene therapy biotech takes aim at Huntington's

Source: 
BioPharma Dive
snippet: 

Passage Bio, a young but prominent company developing genetic medicines for brain and nervous system disorders, has added two more programs to its slate of research projects, including one that will investigate treatments for Huntington's disease.